HIV ribozyme gene therapy (Chiron/Sirna Therapeutics)

N/A

Report date: 2022/02/17 13:40:59

Base Information

Drug NameHIV ribozyme gene therapy (Chiron/Sirna Therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionRibonucleases stimulants
TargetsRibonucleases
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSirna Therapeutics IncChiron Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChironSirna Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A